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Abstract
While current major national research efforts (i.e., the NIH Human Microbiome Project) will enable comprehensive
metagenomic characterization of the adult human microbiota, how and when these diverse microbial communities take up
residence in the host and during reproductive life are unexplored at a population level. Because microbial abundance and
diversity might differ in pregnancy, we sought to generate comparative metagenomic signatures across gestational age
strata. DNA was isolated from the vagina (introitus, posterior fornix, midvagina) and the V5V3 region of bacterial 16S rRNA
genes were sequenced (454FLX Titanium platform). Sixty-eight samples from 24 healthy gravidae (18 to 40 confirmed
weeks) were compared with 301 non-pregnant controls (60 subjects). Generated sequence data were quality filtered,
taxonomically binned, normalized, and organized by phylogeny and into operational taxonomic units (OTU); principal
coordinates analysis (PCoA) of the resultant beta diversity measures were used for visualization and analysis in association
with sample clinical metadata. Altogether, 1.4 gigabytes of data containing .2.5 million reads (averaging 6,837 sequences/
sample of 493 nt in length) were generated for computational analyses. Although gravidae were not excluded by virtue of
a posterior fornix pH .4.5 at the time of screening, unique vaginal microbiome signature encompassing several specific
OTUs and higher-level clades was nevertheless observed and confirmed using a combination of phylogenetic, non-
phylogenetic, supervised, and unsupervised approaches. Both overall diversity and richness were reduced in pregnancy,
with dominance of Lactobacillus species (L. iners crispatus, jensenii and johnsonii, and the orders Lactobacillales (and
Lactobacillaceae family), Clostridiales, Bacteroidales, and Actinomycetales. This intergroup comparison using rigorous
standardized sampling protocols and analytical methodologies provides robust initial evidence that the vaginal microbial
16S rRNA gene catalogue uniquely differs in pregnancy, with variance of taxa across vaginal subsite and gestational age.
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Introduction
To date, the dominant paradigm in Western medicine
considers microbes as ‘‘foreign’’ and has led to the prevailing
view that elimination of predominant pathogens will result in
amelioration of disease. Such a view is seemingly in contrast to
longstanding observations that humans serve as host to co-
evolving microbes residing in highly plethoric communities.
Indeed, microbiota are present from the time of birth, with up
to 10-fold the number of microorganisms to adult human cells
and a collective genome (the ‘‘metagenome’’) which exceeds our
human genome in terms of gene content by more than 100-fold
[1]. Moreover, we appreciate that the human microbiota are
a metabolically and antigenically vibrant and diverse community
which may function as mutualists (symbiotically beneficial),
commensals (of neither harm nor benefit), or pathogens (of host
detriment) [2–4].
Current major national research efforts (i.e., the NIH Road Map
initiative known as the Human Microbiome Project (HMP)) will
enable sequence-based comprehensive characterization of the
adult human microbiota and theoretically allow for cataloguing of
the microbiota into core guilds, which can be thereafter
interrogated for their associations with disease states [1]. Un-
derstanding the processes that govern the structure and dynamics
of these human microbial communities is essential for gaining
a complete understanding of human development and physiology
[5–9]. However, questions pertaining to how and when diverse
microbial communities reside in the host (and how they differ
during an individual’s lifetime) are under-explored at a population-
wide level. In other words, while we may soon know what
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how it is established nor whether it is dynamic during intervals in
reproductive life when the next generation’s microbial community
is being established.
Primate fetal development is thought to occur within an
intrauterine microbiota-free environment, and yet within a short
interval following birth the human microbiome is colonizes and
‘‘differentiates’’ until the adult complement of 90 trillion or so
microbiota is achieved [1,4,7,9]. Based on a relative paucity of
data, it is proposed that the naı ¨ve neonatal microbiome is first
established with rupture of the amniotic membranes, with further
microbiota being introduced as the fetus traverses the vaginal birth
canal. By the time of delivery, the neonate has been exposed to the
maternal vaginal microbial ecosystem [9–12]. Passage through the
vaginal canal is an integral part of this process, as mode of delivery
alters the neonatal microbiome [7–12]. However, since a compre-
hensive characterization of the vaginal microbiome signature in
pregnancy has not yet been undertaken, conclusions regarding
mechanisms of neonatal colonization are likely premature [13–
17]. Since the infant is exposed to several environmental sources of
bacteria in the early neonatal interval (maternal vaginal canal and
feces, swallowing and breathing, skin to skin contact, maternal
breastmilk, etc.) it is important to discern the relative potential
contribution of the maternal vaginal community to the neonate.
Established 16S ribosomal RNA (rRNA) gene sequence-based
methodologies have enabled primary cataloguing of the bacterial
composition of the human microbiome [18–21]. While multiple
studies during the past several years have launched the era of
human metagenomics, few reports have examined microbiomes
outside of the gastrointestinal tract in more than a few individuals
[22–26], and none have systematically examined the vaginal
microbiome throughout pregnancy. Here, we use cultivation-
independent, molecular-phylogenetic techniques to characterize
the first comparative bacterial assemblages across gestational age
strata and in a rigorous clinical study. By interrogating the
‘‘healthy’’ human microbiome in pregnancy and in paralleled
comparison with non-pregnancy, we reasoned that the ensuing
metagenomic profile would optimally reveal the comparative
diversity and richness of microbial species. In this manuscript, we
describe our intergroup comparison using rigorous standardized
sampling protocols and analyses methodologies in order to provide
robust initial evidence that the vaginal microbial gene catalogue
uniquely differs in pregnancy, with variance of molecular
phylogeny (species richness and diversity) across both subsite and
gestational age.
Results
Subject Characteristics
Subject characteristics are as outlined in Table 1.A s
anticipated by our use of a parallel protocol design, comparable
age, pregravid (or nongravid) BMI, race and ethnicity, and
tobacco use were observed among both pregnant and non-
pregnant subjects. Although the enrollment percentages by virtue
of race and ethnicity were distinct in the two cohorts, these
distinctions did not reach statistical significance (p.0.05, both
independent samples t-test and ANOVA). As further anticipated
among pregnant subjects per se, significant variance in medication
use with respect to vitamins and antacids were similarly observed.
Recalling prospective subject enrollment, the majority of gravidae
had uncomplicated pregnancy outcomes: mean gestational age at
delivery exceeded 39 weeks and included appropriately grown
infants (mean 3265 grams), with 2/24 (8%) of subjects delivering
,37 weeks (34 5/7, and 36 6/7 weeks). The cesarean delivery rate
was consistent with the regional population (33%). A single fetal
comorbidity was observed among the cohort after enrollment (fetal
gastroschisis), and a total of 3 subjects manifest 4 comorbidites
common to the obstetrical population (Table 1). Among the non-
pregnant cohort, all subjects were not menstruating at the time of
sampling per study protocol, and 58.8% would be anticipated to
be anovulatory secondary to use of contraceptive (30 of 51
subjects).
Pregnancy Structures the Vaginal Microbial Community
Other investigators have employed cultivation-independent,
molecular phylogenetic approaches to characterizing maternal
microbial communities [9]. In order to leverage our data from the
HMP, we developed a parallel sampling strategy in our 24
pregnant subjects with equivalent stringent screening criteria [27].
Both subject cohorts were sampled in a uniform and highly
consistent manner by a single obstetrician (K.A.) from three
distinct vaginal sites (vaginal introitus, posterior fornix, and
midvagina); all samples employed in this report were extracted
in a single laboratory. With sequencing on the 454 Titanium FLX
platform, our approach yielded robust bacterial 16S V5V3
enriched data sets for subsequent analysis (Table 2). Because we
could not reliably measure nor control for differences in the
sampled area or volume, we focused our analyses within these
microbial communities on shifts in bacterial community structure
and diversity which occur solely by virtue of pregnancy.
As demonstrated in Figure 1, microbiome sequence surveys
with 16S rRNA pyrosequencing reveal primary structuring by
virtue of pregnancy (green versus blue). Given our aim to
ultimately describe the vaginal taxa that contribute to a unique
community structure in pregnancy, we applied both phylogenetic
(UniFrac) and non-phylogenetic (Canberra, Chord, and Ochiai)
methods. As a quality filtering step, each dataset was minimally
(left plots, Figure 1) or modestly (right plots) preprocessed and
applied to a flowgram clustering step for removal of chimeric
sequences (which occur as a byproduct of the PCR-amplification
and pyrosequencing) [28]. This robust analysis approach reveals
evident significant community clustering structured predominately
by pregnancy regardless of method (phylogenetic or non-
phylogenetic) or potential noise for noisy or denoised datasets
(Figure 1).
When beta diversity metrics were considered by virtue of the
vaginal subsite, pregnancy persisted as the primary arbitrator of
community microbial structure (Figure 2A). However, when
assessing alpha diversity (community richness and Shannon
diversity index) with respect to either proximity to the uterus
(posterior fornix, which is just posterior to the cervix, versus the
vaginal introitus or midvagina) or gestational age (interval in
weeks), variable differentiation was observed (Figure 2B). When
within community (alpha diversity) variance was analyzed with
OTU-based methodologic approaches [29–33] the vaginal micro-
biome in pregnancy was equally rich but less diverse than non-
pregnant communities (Figure 2B, left panel). This result was true
in proximity to the cervix and throughout the latter midtrimester
as the cusp of fetal viability (24–32 weeks) is reached. However,
when taxa were analyzed with phylogenetic applications uniformly
projected to the genus level, vaginal introitus and midvaginal
communities preterm were both less diverse and less rich than
either late preterm (.32 weeks) pregnancy or non-pregnant
communities. At the posterior fornix, phylogenetic projections
suggested unchanged communities among pregnant and non-
pregnant (Figure 2B, right panel).
Given our distinct observations with respect to intracommunity
richness and diversity by virtue of taxonomic and phylogenetic
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OTU counts due to sequencing artifacts and/or binning errors.
We therefore measured alpha diversity in both pregnant and non-
pregnant vaginal communities with AbundantOTU (Figure 3,
left panels) and QIIME denoising (in addition to chimera and
singleton removal) (Figure 3, right panels). Although these
denoising pipelines did, in fact, differ in their assessments of
sequencing noise (and thus resulting OTU counts), both resulted in
significant and robust differences among the pregnant (black lines)
and non-pregnant (red lines) vaginal microbial communities. They
also agreed in that community diversity in pregnancy is both
significantly less rich (rarefaction metrics for microbial richness or
taxa quantification, Figure 3A) [34] and less diverse (Renyi
metrics for microbial diversity or number of distinct taxa,
Figure 3B) [34–37]. Taken together, these data are consistent
with the notion that community aggregates to genus level
projections (Figure 2B, right panel) are unchanged in the
posterior fornix, but the more robust analysis of genus and sub-
Table 1. Subject Characteristics and Pregnancy Outcomes.
Subject Demographics Pregnant n=24 Non-Pregnant n=60
Subject age (mean, years) 31.4 (5.8) 26.9
BMI (kg/m2) at sampling 30.4 (7.3) 23.9
BMI (kg/m2) prepregnancy 27.6 (7.6) NA
Ethnicity/Race
Hispanic 4 (16%) 11 (18%)
Non-Hispanic 15 (63%) 35 (58%)
Black or African American 3 (13%) 3 (5%)
Other 2 (8%) 11 (18%)
Tobacco Use
Yes 24
No 22 56
Medication (Category)
Vitamins or supplements 24 7
Endocrine metabolic agents 1 7
Antacids/H2 antagonists 11 2
GI medication (Antiemetics and stool softeners) 3 2
Pregnancy Outcomes
Mean gestational age (weeks) 39 weeks 2 days
Preterm birth ,37 weeks (rate) 8% (34 5/7, 36 6/7 weeks)
Mean birthweight (grams) 3265 g
Mean Apgar score
1 minute 8
5 minute 9
Cesarean delivery (rate) 33%
Vaginal delivery (rate) 67%
Comorbidities
(3 subjects with 4 comorbidities) GDMA1, fetal gastroschisis, mild preeclampsia, severe preeclampsia
Characteristics of both pregnant (gravidae) and non-pregnant subject cohorts, alongside pregnancy outcomes of the gravid cohort. GDMA1, gestational diabetes
mellitus White classification A1 (diet controlled). There were no significant differences with respect to Race/Ethnicity among gravidae and non-pregnant subjects
(p.0.05 by independent samples t-test and ANOVA).
doi:10.1371/journal.pone.0036466.t001
Table 2. V5V3 Sequence Metrics.
Subject cohort
Number of
Subjects
Number of
Samples Total Sequences Average Sequence Length
Average
Sequences/Sample
Pregnant 24 68 670,921 498 nt 9,867
Non-pregnant 60 301 1,852,039 491 nt 6,153
Combined 84 369 2,522,960 493 nt 6,837
Sequence metrics for the pregnant (gravidae), non-pregnant, and combined cohorts. Pregnant subject’s samples were of comparable average sequence length, but
retained a higher average number of sequence reads per sample.
doi:10.1371/journal.pone.0036466.t002
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less rich community structure in pregnancy (Figure 3).
Taxa Contributing to the Unique Vaginal Microbiome in
Pregnancy
Given the robust evidence that the structure of the vaginal
microbiome significantly differs in pregnancy (Figures 1 and 2),
and further evidence suggesting that the pregnant microbial
community is less diverse and rich (Figure 3), we next sought to
identify which bacterial taxa were contributing to an altered
community in pregnancy. OTU tables and representative
sequences generated from AbundantOTU (Figure 4A) and
QIIME denoised (Figure 4B) datasets were employed in
generating global phylogenetic trees. Additionally, the RDP
classifier was used to assign taxonomy and label each element in
the OTU table, and the resultant alignment enabled character-
based construction of a phylogenetic tree from the filtered NAST
alignment using FastTree [38]. Clear family (internal cluster with
annotations in figure legend) and order level (middle circle)
differences in the pregnancy microbiome are visible in both
datasets (Figure 4), with an overall predominance of the order
Lactobacillales (and Lactobacillaceae family), followed by Clostri-
diales, Bacteroidales, and Actinomycetales. Distinctions between
pregnant and non-pregnant communities by unweighted phylo-
genetic clustering are observed and annotated in the outermost
circle (Figure 4).
Finally, to identify the specific taxa differentially present or
abundant in the vaginal microbiome in pregnancy, we employed
two complementary supervised machine learning approaches. The
first, the random forest algorithm paired with Boruta feature
selection, was validated on classification of subjects by their vaginal
microbiome with a pi statistic (improvement over random)
exceeding 0.8 at OTU abundance thresholds of 100 or 500 for
the AbundantOTU data set (Figures S1 and S2, Tables S1 and
S2) and likewise above 0.6 for the QIIME denoised data set
(Figure S1, Tables S1 and S2). Pregnancy status was, in fact,
the single feature best predicted by the microbiome (as opposed to
BMI, vaginal site of sampling, and ethnicity), and sub-sites were
not well distinguished (pi statistic of discrimination ,0.2 in all
cases; Tables S1 and S2, Figure S3 with binned taxonomy).
Using Boruta feature selection during RF analysis, 12 specific taxa
were identified as discriminating between pregnant and non-
pregnant cohorts at the genus level (at $80% bootstrap cutoff,
Figure S1). In order to identify a taxonomic biomarker with high
stringency, we additionally employed the LEfSe method [39],
which confirmed the differential abundance of 29 and 27 clades
(AbundantOTU and QIIME data, respectively, using default
significance and LDA thresholds) at all taxonomic levels between
pregnant and non-pregnant microbiomes (Figure 5). Supporting
our findings in Figures 3 and 4, these comprised primarily specific
Lactobacillus OTUs and potentially the Bifidobacteriaceae and
Streptococcaceae. Our findings suggest that the composition of the
microbial community in pregnancy represents a relatively di-
minished profile of species richness and diversity (Figures 2, 3, 4,
5), culminating in the specific reduction of many usual vaginal
community members and enrichment for a targeted set of
Lactobacillus species (Figure 5). We present the species-level data
in Table S3. Briefly, OTUs generated from AbundantOTU and
QIIME were aligned to the Greengenes database with the top
OTUs identified by LEfSe (Figure 5A). OTU sequences selected
by Boruta feature selection are deposited in GenBank and are
presented in Figure S2 and Table S3. Top OTUs identified by
LEfSe are marked with an asterics. For example, AbundantOTU
generated consensus 2/33 aligned to Lactobacillus iners, consensus
102/84/70/98/67/44/29/46 to Lactobacillus crispatus, and consen-
sus 28 to Lactobacillus jensenii. On QIIME, 882 aligned to
Lactobacillus johnsonii, and 322 to Lactobacillus crispatus.
Discussion
With a robust sampling, sequencing, and analysis approach, we
generated the first comprehensive catalogue of the vaginal
microbiome in pregnancy across subsite and gestational age.
When compared to the non-pregnant vaginal microbiota, the
community is uniquely and distinctly structured during pregnancy
(Figure 1 and 2A), in ways that cannot be attributed to alterations
in BMI (Tables S1 and S2), to subject race or ethnicity, nor to
readily identifiable clinical confounders. Interrogations of discrete
contributors to community diversity revealed that the vaginal
microbial community varied in pregnancy by gestational age and
proximity to the cervix, but was less diverse and less rich overall
(Figures 2B and 3). To our knowledge, this structured molecular
study of gravidae is unique in terms of stringency of a parallel
clinical approach, sample acquisition from subjects, depth and
robustness of analysis, and notable findings. In sum, the vaginal
microbiome is distinctly structured by a state of health in most
women’s lifetime, i.e., pregnancy.
Others have taken similar but limited approaches to in-
terrogating the vaginal microbiota in pregnancy. Dominguez-
Bello utilized 16S 454-generated molecular signatures to generate
vaginal profiles in a limited sample set of 9 subjects at term with
delivery (including non-laboring and active laboring mothers) from
a remote population of Amerindians [9]. In this small sample set,
the dominant vaginal taxa varied from mother to mother, also
with notable variance in Lactobacillus spp. However, these
investigations did not include parallel sampling of both non-
pregnant and pregnant subjects, nor from multiple vaginal subsites
[9]. However, this study was remarkable for its parallel acquisition
of neonatal microbial community sampling. As supported by other
studies [4–12], the infant gut microbiome largely reflects the
maternal mode of delivery, although it bears mention that in
several studies women were delivered by cesarean for obstetrical
indications in active and advanced labor thereby revealing
a potential bias by virtue of infant handling in cesarean and
vaginal birth and not solely a reflection of fetal descent via the
birth canal [9–12].
Our study suggests that although human adults have highly
differentiated bacterial communities that are relatively stable [3–
6,13–17], in such prevalent and healthful states as pregnancy the
vaginal community in particular shifts naturally in its structure
with respect to diversity and richness. Indeed, Ravel et al have
previously reported that the vaginal microbiome in healthy,
reproductive-aged women occupies states dominated by Lactoba-
Figure 1. Beta diversity metrics of bacterial 16S rRNA genes reveal distinctly clustered vaginal microbiome communities structured
by pregnancy. Datasets were minimally filtered for removal of singletons (left panels) or filtered for chimeras (right panels; QIIME ChimeraSlayer).
Beta diversity microbiome community clustering is observed for non-phylogenetic methods ((A) normalized Canberra), binary non-phylogenetic
methods ((B) binary Chord, (C) binary Ochiai), and phylogenetic beta diversity metrics ((D) unweighted UniFrac). In each panel, each point
corresponds to a vaginal sample from either a pregnant (green) or non-pregnant (blue) subject. The percentage of variation explained by the plotted
principal coordinates is indicated on the axes.
doi:10.1371/journal.pone.0036466.g001
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e36466Figure 2. Subclassification of microbial community structure by vaginal subsite and week of gestation. (A) Pregnancy clusters vaginal
microbial communities, while site of vaginal sampling minimally contributes to within cluster formation. Canberra beta diversity metric with PCoA
plot clustering. Each dots represents one sample from the distinct vaginal subsites (mid vagina, posterior fornix, and vaginal introitus) of individual
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low vaginal pH [40]. Others speculated [41] that vaginal
community changes with pregnancy, but ours is the first direct
evidence as such. Indeed, our findings suggest that at least among
reproductive aged women, the vaginal microbiome remains
a dynamic community in adult reproductive life, and that terminal
differentiation does not occur per se [41]. Moreover, we observe
persistent relative prevalence (but not sole nor absolute pre-
dominance) of Lactobacillus (Figure 4, AbundantOTU). However,
across the entirety of our study population, less diversity and
richness occurred in measured variance throughout weeks of
gestation and in proximity to the uterus (posterior fornix), leading
us to speculate on variances within the cusp of preterm viability.
Of interest, in subjects closer to term OTU-based projections
suggest that the non-pregnant community structure may return to
some extent in the latter weeks of gestation. Our study is
potentially limited by employing a cross-sectional comparison in
gravidae (Figure 2), relative to a limited number of non-pregnant
subjects with multiple samplings (18/301 specimens represented
thrice sampling, see methods). Alternatively, when we compared
only first samplings of non-pregnant women to gravidae, we still
observed consistent cluster separation (data not shown). The most
subjects from pregnant (green shades) and non-pregnant (blue and purple shades). (B) Among gravid subjects, microbial community richness and
diversity (Shannon indices) vary by week of gestation and proximity to the uterus. Community richness and Shannon diversity indices by gestational
age and vaginal sampling site against normalized abundance values from both OTU and phylogeny based analysis charted by vaginal site (posterior
fornix, mid vagina, introitus) and gestational age. Richness - Black; Diversity – Dark Red; Left panel designates OTU based; Right panel designates
Phylogeny based. Gestational age interval shown in weeks, or designated as non-pregnant (NP). Error bars denote variance (standard error of the
mean, s.e.m.). In each of the gestational age intervals, an equivalent number of gravidae were sampled and compared (n=6 per strata).
doi:10.1371/journal.pone.0036466.g002
Figure 3. Measures of within community diversity (alpha diversity) at two levels of data filtering. Black lines indicate pregnant cohort,
with red lines indicating non-pregnant cohort. Data sets were subjected AbundantOTU (left panels), or denoising and chimera slaying with removal
of singletons and chimeras (right panels). (A) Rarefaction alpha diversity metrics note significantly lower richness in the pregnant data set, while (B)
Renyi alpha diversity metrics indicates significantly less diversity among pregnant vaginal communities following denoising. Significance is denoted
by the absence of curves crossing over at any point following denoising and chimera slaying (right panels).
doi:10.1371/journal.pone.0036466.g003
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would be to employ a longitudinal approach whereby each subject
is sampled at ongoing weekly intervals across pregnancy.
However, that is outside the scope of this initial study.
We opted to employ a parallel sampling strategy by stringent
inclusion and exclusion criteria to the Human Microbiome
Project. While this enabled us to make true comparisons to
a large, robust, and unparalleled dataset of non-pregnant subjects,
it similarly opened the possibility that we were sampling an
unperturbed but not ‘‘normal’’ population. However, it bears
mention that our outcomes among gravidae were entirely what
might be anticipated in a health pregnant population (Table 2),
and did not differ significantly among subjects. As with all large
human cohorts, our study is prone to both alpha error and
induced bias. We attempted to minimize error and bias with
a single physician performing all subject sampling among both
cohorts, and all samples being extracted from primary specimens
within a single laboratory utilizing a common and rigorously tested
protocol (HMP).
It remains a distinct possibility that our significant observed
community clustering with the vaginal microbiome being
evidentially structured by pregnancy reflects a secondary trait
in our pregnant population, but not gravid condition itself. Of
note, we did not exclude gravid subjects by virtue of posterior
fornix vaginal pH. In contrast, in the non-gravid HMP cohort
subjects were excluded at the time of screening if the posterior
fornix pH exceeded (see Methods). Given that ,10% of screen
failures (and ,4% of the entire potential cohort) met such pH
criteria for exclusion, we feel that this is an exceedingly unlikely
potential confounder or bias. However, it cannot be formally
excluded as such. To this end, in the recent publication of
Ravel et al., [40], the authors reported that while the pH and
Nugent scores of each community demonstrated strong corre-
lation between high pH and high Nugent scores and the highest
pH values were associated with community states not dominated
by species of Lactobacillus. It is of importance to note that these
investigators employed self-sampling in their study. Nevertheless,
the investigators also reported that elevated pH and high
Nugent scores were observed in some communities with high
proportions of lactobacillus species and that this was most true
in communities which contained decreasing proportions of L.
iners. However, this was not universally true, leading the authors
to summize that these metrics cannot be predicted with absolute
certainty solely on the basis of the proportion of Lactobacillus in
Figure 4. Global phylogenetic trees after AbundantOTU and QIIME denoising. Global phylogenetic trees show the distribution of
taxonomy among all the pregnant and non-pregnant subject samples. The internal cluster dendrograms are colored by taxa Family level projections
(annotated in figure legend), while the mid-circle is colored by the majority origins of OTUs from pregnant or non-pregnant subject samples
(pregnant-magenta; non-pregnant-brown). Outermost circle using text to indicates OTU projection to Order level (Bacteroidales-red,
Actinomycetales-yellow, Lactobacillales-green, Clostridiales-blue). OTU tables and representative sequences generated from AbundantOTU
(Figure 4A) and QIIME denoised (Figure 4B) datasets were employed in generating these global phylogenetic trees.
doi:10.1371/journal.pone.0036466.g004
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statements, and note that when comparing our population of
pregnant subjects to the non-pregnant HMP cohort we observed
community discrimination by virtue of Lactobacillus species,
namely L. iners, L. crispatus, L. jensenii and L. johnsonii. If our
community distinctions were the result of an incidental inclusion
of pregnanc subjects with a posterior fornix pH .4.5, then we
would anticipate potentially seeing a decreasing proportion L.
iners in the community structure. However, the opposite holds
true (Figure 5) making confounding by version of pH unlikely.
As the number and robustness of computational approaches to
analysis of metagenomics data increases, investigators are faced
with distinct methodologic approaches to analyzing community
profiles. In any emerging field of study, optimal measures of data
analysis are not evident to investigators at the forefront and
different methodologic approaches may yield variance in signif-
icance of findings [28,42–46]. With this in mind, we employed
a diverse and robust set of bioinformatic tools in analysis of our
datasets (see Methods). For community cluster distinction (beta
metrics), we analyzed taxa by nonphylogenetic and phylogenetic
methods. Regardless of distance metric or phylogenetic analysis,
the vaginal microbiome distinctly clustered by virtue of pregnancy
(Figures 1, 2A, and 4). As AbundantOTU uses a consensus
alignment algorithm, thus tending to concentrate on OTUs of
greater abundance. Detection of rare species is difficult to
differentiate from sequencing error. QIIME denoiser preempts
this difficulty with a pre-filter to reduce the needs of all-on-all
comparison; each additional unclustered read is compared to the
most abundant clusters to discern sequencing error probability
from detection of rare bacterial species retained in the OTU table.
Regardless of methodology, our results from AbundantOTU and
QIIME denoising are strikingly similar in terms of differentiating
OTU identified (Figure 4). This finding is further evident at the
species level, as detailed in Figure 5.
Similarly, for measurement of within community diversity
(alpha) we employed variations in data filtering ranging from
minimal removal with scant trimmed reads to well-described
modest ‘‘denoising’’ and slaying of chimeras. We persistently
observed less richness and diversity in pregnant communities when
compared with parallel non-pregnant subject cohorts, regardless of
computational pipeline, tool employed, or means of data pro-
jection (Figures 2B and 3). The limited results analyses at the
genus level, and the number of significantly differential OTUs
(Figure 5), both suggest that it is subgenus taxa that most strongly
contribute to observed alterations in community structure in
pregnancy. This was supported by two complementary rigorous
denoising approaches to our dataset. AbundantOTU and QIIME.
The former resulted in diminished OTU estimates (868 versus
1,121 OTUs), but both agreed in the predominance of lactobacilli
(Figure 4) irrespective of gravid condition and clades differential
during pregnancy (Figure 5). With QIIME denoising, a broader
set of taxon differences and less absolute predominance of
Lactobacillus could be observed. While each denoising pipeline
has its own strengths and limitations, one undeniable observation
persists: the vaginal microbiome community is structured by
pregnancy and varies with respect to richness, diversity, and
specific microbial members.
Employing such robust analyses methods, we were able to
detect species which are discriminately and specifically relative
enriched in pregnancy (albeit in the face of overall diminished
community richness and diversity). These include Lactobacillus iners,
Lactobacillus crispatus, Lactobacillus jensenii and Lactobacillus johnsonii.
Although it is outside the scope of this initial manuscript to delve
deeply into the species differentiation and clinical implications,
these findings are of probable biologic significance nevertheless.
For example, L. johnsonii encodes enzymes and transporters
essential for the release bile salt hydrolase and is primarily found
in the upper GI tract [47]. In addition, the capacity for production
of bacteriocins is a broad trait of the lactic acid bacteria and L.
johnsonii production of Lactacin F both limits other lactobacillus as
well as Enterococcus species in the GI tract. It’s notable increased
dominance in the vagina in pregnancy may be important for
establishing the neonatal upper GI microbiota upon delivery, or
preserving the integrity of the community to reduce risk of
ascending infection or preterm birth.
The vaginal microbiome signature in pregnancy is thus distinct
from non-pregnant, and this distinction comprises both from lesser
diversity and, to a lesser degree, from the absence and occasionally
presence of unique taxa. Our reporting by gestational age and
vaginal subsite now lays the foundations for further interrogations
into microbial variance, including such presumed pathogen-
related perinatal morbidities as preterm birth. Moreover, it lends
to the growing understanding of the remarkable dynamic nature of
our metagenome and its role in vertical transmission of the
microbiota through subsequent generations.
Materials and Methods
Subjects
The intent of this study was to compare the vaginal microbiome
in pregnancy from healthy individuals whose core microbiomes
were likely to be minimally perturbed by virtue of infectious
comorbidities and exogenous exposures. We took advantage of our
role as clinical investigators with the Human Microbiome Project
(K.A., J.P., and J.V., Baylor College of Medicine) [27] and
employed parallel recruitment of non-gravid (non-pregnant) and
gravid subjects using rigorous standardized sampling protocols.
Subjects were recruited from the general population with general
media and institutional advertisements, in addition to institutional
study enrollment web sites and approach during previously
scheduled clinical appointments. An initial telephone query
included a general health questionnaire to screen interested
individuals who would be evaluated by a list of inclusion/exclusion
criteria including a pre-pregnancy or current body mass index
range of 18–35, history of cancer, compromised immune status,
history of specified chronic diseases, or medication exposure
within the last six months (e.g., antibiotics, corticosteroids,
cytokines, large doses of probiotics, etc.). Major dietary changes
and history of moderate-high alcohol intake excluded individuals.
Medications and dietary components that potentially might alter
the human microbiome intentionally such as antibiotics and
probiotics served as additional important exclusion criteria.
Figure 5. Metagenomics-based discovery of bacterial taxa contributing to differentiation of vaginal communities in pregnancy.
Bacterial taxa were selected as significantly differentially abundant between pregnant and non-pregnant communities (regardless of sampling site)
by the LDA Effect Size (LEfSe) algorithm, (left panel) sorted by degree of difference (listing only taxonomic leaves) and (right panel) overlayed on
a complete taxonomy. Taxa are again reduced in diversity during pregnancy, with several specific Lactobacillus OTUs detected uniquely among
pregnant individuals. OTU tables and representative sequences generated from AbundantOTU (Figure 5A) and QIIME denoised (Figure 5B)
datasets were employed in LEfSe analyses.
doi:10.1371/journal.pone.0036466.g005
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cycle or a history of regular cycles prior to beginning contraception
or at the time of conception, and the use of specific contraceptives
such as the combination hormone vaginal ring was exclusionary in
non-gravid subjects. For gravidae, inclusion criteria additionally
detailed best obstetrical dating for gestational age, defined as
reliable last menstrual period consistent with ,12 week sonogram
or ,10 week sonographic dating with unreliable last menstrual
period. At the time of enrollment, all gravid subjects had presumed
normal singleton gestations and were without known maternal
comorbidities (such as type II DM, gestational diabetes type A2,
hypertensive disorders, or chronic medical conditions). However,
given the prospective nature of the study with early second
trimester enrollment, some subjects developed these comorbidities
(Table 1). Individuals who remained interested in the study and
met study criteria were invited for a screening visit in the research
clinic (non-gravid), or approached at their next scheduled clinic
visit (gravid).
Atthescreeningvisit,thestudyandassociatedriskswereexplained
and subjects documented informed consent by signing a study
consent form. Investigators determined final study eligibility by
taking a medical history and performing a review of systems,
documenting concomitant medications, measuring vital signs,
collecting urine for pregnancy testing (non-gravid) and either
obtainingbloodforserumHIV,HBVandHCVtestingorreviewing
previously obtained serologies (all required to be negative). In
addition, all subjects underwent targeted physical exams with
attention to body site-specific exclusion criteria (oral cavity, skin
andnasalcavity),andamongnon-gravidsubjectsmeasuringvaginal
pHinfemales(pH.4.5atposteriorfornixwasexclusionary).Gravid
subjects did not undergo vaginal pH measurements as per study
protocol limitations but were queried as to signs and symptoms of
bacterialvaginosisandexcludedifreported.Individualswhopassed
all screening criteria were eligible for enrollment and were sampled
thefirsttimewithin30daysofthescreeningvisit(non-gravid),oratthe
timeoftheprenatalvisit(gravid).Althoughexclusionofnon-gravidae
forposteriorfornixpH.4.5atthetimeofscreeningwasexceedingly
rare(notablywithonly22of254screenfailuresintheHMPoccurring
by virtue of vaginal irritation or posterior fornix pH.4.5; 554
potential subjects were screened to ultimately enroll 300 in total for
the HMP [http://www.hmpdacc.org/micro_analysis/
microbiome_sampling.php]), it remains a formal possibility that
ourcohortcomparisonmaybebiasedasposteriorfornixpHwasnot
an exclusionary criteria inour pregnant cohort.
For the non-gravid (non-pregnant) comparison cohort, of the
150 females from the HMP JumpStart initiative [18,19] all
individuals were designated for study enrollment a priori.
Enrollment criteria were established at approximately 20%
minority (racial and ethnic) subjects. While in the index study
protocol, two ethnically, racially, and socieconomically diverse
U.S. cities (Houston, Texas and St. Louis, Missouri) served as
geographically distinct study sites for clinical sampling for this
comparison. However, only subjects sampled at Baylor College
of Medicine were considered in the comparison cohort. This
served to limit potential additional variables, including personnel
doing the sampling (all gravid and non-gravid subjects were
sampled by one investigator [K.A.]), site of microbial DNA
extraction, and regional variability. To assure compliance of
screening and sampling measures, a common set of human
study protocols and consent forms were created, reviewed
independently and subsequently approved at Baylor College of
Medicine. An age range of 18–40 years was established to
minimize variability due to childhood growth and development,
aging, and hormonal influences during adolescence and
menopause. Each of the enrolled non-gravid subjects agreed
to primary and repeat (second) sampling so as many individuals
as possible were sampled twice. A subset of non-gravid subjects
was designated to undergo three samplings at each body site, at
a priori designated intervals.
Subject Compliance/Protection and Informed Consent
Specimen collection procedures involved minimal physical
risk to subjects. As defined in 45 US Code of Federal
Regulations (CFR) 46.102 (i), ‘‘Minimal risk’’ infers that the
‘‘probability and magnitude of harm or discomfort anticipated
in the research are not greater in and of themselves than those
ordinarily encountered in daily life or during the performance
of routine physical or psychological examinations or tests.’’
Potential risks of participation as discussed with subjects
included those associated with biologic sample collection and
repository, and the unintentional release of protected health
information; the protocol and informed consent form described
precautions taken to reduce these risks. The study sites
developed informed consent documents using NHGRI guide-
lines for genomics studies, which address the ethical, legal and
social implications of such research. The Institutional Review
Board reviewed and approved the protocol, informed consent
and other study documents. Additional protections for subjects
included Certificates of Confidentiality intended to protect
against the forced disclosure of identifiable research data,
coding of genomic and metagenomic specimens and sequence
data, and use of controlled access databases for medical data
and human genome sequence data. As part of the consent
process, we informed subjects about data protection, including
coding, use of controlled-access databases for human genomic
data and controlled-access repositories for extracted metage-
nomic nucleic acids. If a subject withdrew consent after
providing specimens, remaining specimens and extracted nucleic
acids were to be destroyed; however, any metagenomic
sequence data that was already published in open access
databases could not be retracted.
Clinical Metadata Collection
EMMES and the Data Analysis and Coordination Center for
the Human Microbiome Project (www.hmpdacc.org) established
an internet data entry system for investigators to enter coded
non-gravid subject information; gravid subject information was
entered and maintained on a local database with secured
protection but not released to the DACC. Clinical data
elements included gender, race, ethnicity, age, place of birth,
occupation, body mass index, vital signs, vaginal pH (non-
gravid), date of last menstrual period and first sonogram,
tobacco use, and both dental and health insurance status. A
medical history, comprehensive obstetrical data, and targeted
physical examination findings alongside medication history were
also recorded for each subject.
Specialized Reagents and Instrumentation for Human
Sampling
The Catch-All swab from Epicentre Technologies was selected
as the swab of choice for sampling based on preliminary
evaluations done in conjunction with HMP. The Catch-All swab
was used for collection of all vaginal samples. Prior to vaginal
sampling in non-gravid subjects, a digital display pH meter with
accuracy to .0.01 was employed for precision measure of vaginal
pH (Waterproof BigDisplay pH Spear, Oakton pH meter, Vernon
Hills, IL.).
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Inclusion criteria included stringent requirements as otherwise
detailed [27]. Healthy, young adults (ages 18–40) who retained the
ability to provide informed consent and were willing and available
to provide samples during the study interval were targeted for
enrollment. In non-gravid subjects, specimen types included
anterior nares, oral cavity (9 samples), peripheral blood, skin (4
samples), stool, and vaginal (3 samples per female) samples [27]; in
gravidae, only vaginal samples at the posterior fornix, midvagina,
and vaginal introitus were collected. All subjects were required to
have a minimum of 24 teeth with no more than 8 missing teeth.
Three vaginal specimens were collected in a systematic and
uniform fashion from the vaginal introitus, the posterior fornix,
and the midpoint of the vagina. All specimens were collected using
sterile Catch-All
TM specimen collection swabs by applying the
swab to a single site, swirling it 6 times, and then withdrawing
from the site without contamination. The protocol for collection
was as follows: in non-gravid subjects, the pH was measured at the
vaginal introitus (Oakton pH meter, Vernon Hills, IL) and among
both cohorts the vaginal introitus specimen was collected first. A
clear, small or medium Pederson speculum (manufacturer) was
thereafter introduced in the absence of lubrication, and turned to
an approximate 45 degree angle to enable placement of the
Oakton pH meter at the posterior fornix for determination of
posterior fornix pH (non-gravid subjects). In both gravid and non-
gravid, the posterior fornix sample was collected, then the
speculum was slowly withdrawn to the midpoint of the vagina
and the midpoint specimen was obtained. Subjects were not
menstruating on the days of specimen collection and were
abstaining from sexual intercourse, douching, tampon usage or
vaginal creams for the preceding 48 hours.
Specimen Processing
In this study protocol, vaginal specimens were coded, stored
and processed for nucleic acid extraction at a single laboratory
(J.P.) using a common protocol to reduce variability between
samples. Genomic DNA was isolated on standard protocol with
PowerSoil DNA Isolation Kit (MoBio) per HMP modifications
(http://www.hmpdacc.org/doc/
HMP_MDG_454_16S_Protocol_V4_2_102109.pdf).
16S Metagenomic 454 Sequencing Data Generation
Extracted DNA samples were used for 16S rRNA sequence-
based survey. High Fidelity PCR reactions were performed in 96
well plates. 16 mL of master mix composed of 13.85 mL RNAse/
DNAse free water, 2 mL 10X AccuPrime PCR Buffer II, and
0.15 mL AccuPrime
TM Taq DNA Polymerase (Invitrogen) were
mixed into individual wells in the 96 well reaction plate. The
covered plate was spun and centrifuged at 2000 rpm to collect
sample at the bottom of the wells. For the initial reaction, a 2 mL
sample of DNA was added to the reaction wells. Barcoded primers
(2 mM) from the primer plate were added to corresponding wells
in the 96 well PCR plate. Two different PCRs were set up
separately with a set of barcoded primers targeting the V3V1
region and V3V5 regions; this analysis examined V3V5 regions.
The V3V5 regions of the 16S rRNA gene were amplified by PCR
using bar-coded universal primers 354F and 926R (V3-V5)
containing the A and B sequencing adaptors (454 Life Sciences,
Branford, CT) obtained from Invitrogen. Primer sequences are
as follows:B-354F(59-cctatcccctgtgtgccttggcagtctcaGCCTACGG-
GAGGCAGCAG-39; B adaptor in lowercase letters); A-926R
(59ccatctcatccctgcgtgtctccgactcagNNNNNCCGTCAATTCMTT-
TRAGT; A adaptor in lowercase letters, and N represents a bar
code that is unique for each sample). Cycling conditions were
95uC for 2 min, followed by 30 cycles at 94uC for 20 s, 50uC for
V3V5 primer sets. PCR products were cleaned using AmPure
Beads Agencourt (Beckman Coulter, Beverly, MA) using 1.86
volume beads. Beads were eluted with 25 mL1 6low TE, pH 8.0
and transferred to a new 96-well plate. PCR products were
quantified using Quant-IT dsDNA high sensitivity assay (Invitro-
gen) according to the manufacturer’s specifications. All samples
were diluted according to the sample that had the lowest
concentration. Equal volumes of each (5–10 mL) sample were
pooled and then concentrated using MinElute columns (Qiagen,
Valencia, CA). DNA pool emulsion PCR amplification and 454
sequencing were performed at the BCM Human Genome
Sequencing Center (HGSC) in Houston, TX. Sequencing was
performed using the 454/Roche B sequencing primer kit in the
Roche Genome Sequencer GS-FLX Titanium platform. Samples
were combined in a single region of the picotiter plate such that
approximately 20,000 to 40,000 sequences were obtained from
each group with each primer set. Samples were isolated and
quality-filtered from each multiplexed Standard Flowgram Format
(SFF) file.
In the gravid sample cohort, three subjects did not have valid
sequences from a total of 4 body sites (subject 14 did not have valid
sequences from midvagina nor posterior fornix, and subjects 6 and
9 did not have from the midvagina and posterior fornix,
respectively). In the non-pregnant cohort, 29 subjects were
sequenced for all three vaginal subsites 1 time (29 of 301 samples),
21 subjects for all three subsites twice (42 of 301 samples), 6
subjects thrice (18 of 301 samples), and 2 subjects for all three
subsites four times (8 of 301 samples).
Denoising Data Sets
As a quality filtering step, each sample was preprocessed to
remove sequences with length less than 200 nucleotides and
sequences with minimum average quality less than 20. If they
could be identified, reverse primers were also removed from
sequences. In a first pass denoising, singletons and chimeric
sequences (which occur as a byproduct of the PCR-amplification)
were identified by ChimeraSlayer [28] and removed from the
representative sequence file generated by the output of the
minimal filtering pipeline and subsequent OTU table.
For second pass denoising, two programs were employed:
AbundantOTU [29] and the QIIME denoising pipeline. Abun-
dantOTU is a robust and fast OTU picking approach, which uses
a consensus alignment algorithm to infer consensus sequences
from full-length 16S pyrosequences. Since it relies on sequence
redundancy, sequencing errors will have less effect on the OTU
picking process compared with other clustering based methods.
Rare species, which tend to cause inflated species diversity
estimations [30], are not included. In our case, 87% of all input
sequences were assigned to 194 consensus sequences. For QIIME
denoising, the sequences from all samples were processed through
QIIME’s 454 dataset denoising pipeline (version 1.3), whereby the
sff files from 301 non-pregnant samples and the sff file from the 68
pregnant samples were grouped into one complete dataset for
denoising [31], resulting in the production of an OTU table for all
369 samples in a single run on a local cluster utilizing 75
processing cores [32,42,43]. Chimeric sequences in the represen-
tative sequence sets picked from denoised fasta files were detected
by ChimeraSlayer and subsequently removed from the OTU
table. In order to account for artifacts that may arise from multiple
sequencing runs and separate denoising runs, all samples were
denoised together in all alpha diversity, supervised and un-
supervised learning, and feature selection pipelines.
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RDP pipeline. Unique reads were classified with the MSU
RDP classifier v2.2 [44], maintained at the Ribosomal Database
Project (RDP 10 database, version 6), and normalized data were
produced from the relative abundance of taxa present in each
sample based on a naı ¨ve Bayesian classifier [28,43–45]. Output
sequences were classified as domain, phylum, family and genus,
depending on the depth of reliable classifier assignments.
Combined sample reports included the total counts and normal-
ized (relative abundance) data.
Creating input data. QIIME was utilized to produce OTU
tables from the quality-filtered sequences as outlined above [28–
32,42–44]. The generated OTU tables combined with the clinical
metadata comprised the data matrix used as input for alpha
diversity (biodiversity within a group of samples), beta diversity
(biodiversity between groups of samples) [3], and machine learning
pipelines (randomForest). Quality filtered sequences were analyzed
using three standard microbiome analysis techniques: operational
taxonomic unit (OTU) generation, phylogenetic tree construction,
and taxonomic binning of classified sequences.
Alpha diversity. A custom in-house pipeline has been written
to calculate alpha diversity measurements and plots using R
packages [46]: BiodiversityR [48] and vegan [49]. This pipeline
was designed to utilize the output of the OTU picking step (OTU
table and meta data file) as the only necessary input. Analyzing the
biodiversity within a group of samples provides insight into the
differences in species richness, evenness, abundance; we employed
the methods of Chao1 [35] and Shannon [36] as we were
analyzing groups of samples. Plots were generated and exported
for species richness, rank-abundance, and Renyi’s diversity indices
[34] whereby species richness plots depict the number of species
(OTUs) on the y-axis and the number of sites (samples) on the x-
axis such that rank-abundance curves rank and list the most
abundant OTUs from left to right on the x-axis and top to bottom
on the y-axis. The width of the curve on the on the horizontal axis
of a species richness plot serves as an indicator of richness: a wide
curve indicates higher species richness and a narrow curve
indicates the opposite. The shape of the rank-abundance curve is
an indicator of species evenness: a horizontal curve indicates
a completely evenly distributed system, whereas a steep curve
indicates a less even distribution of species [48]. Rank abundance
has been demonstrated to successfully show the extent that tag
pyrosequencing illuminates the rare biosphere of the human gut
[37]. Based on prior evidence, we assumed that Renyi diversity
profiles are helpful in analyzing the differences in diversity and
evenness between multiple subsets of samples [34,37,50]. If the
curves from one sample set contain greater y-axis values, then it
can be concluded that this sample set has greater diversity.
However, if the two curves intersect at any point, the sample sets
are said to be non-comparable, which may reflect important
ecological processes [51].
Beta diversity. Beta diversity analysis incorporated 9 binary
non-phylogenetic (binary chi-square, binary chord, binary Euclid-
ean, binary Hamming, binary Jaccard, binary Lennon, binary
Ochiai, binary Pearson, and binary So ¨rensen-Dice), 14 non-
phylogenetic (Bray-Curtis, Canberra, Chi-square, Chord, Euclid-
ean, Gower, Hellinger, Kulczynski, Manhattan, Morisita-Horn,
Pearson, Soergel, Spearman rank, and species profile), and 6
phylogenetic (UniFrac G metric, UniFrac full tree, unweighted
UniFrac, unweighted UniFrac full tree, weighted normalized
UniFrac, and weighted UniFrac) beta diversity metrics [51–54].
Each beta diversity distance metric calculated was systematically
displayed for the top 3 principal coordinates (PCoA (Principal
Coordinates Analysis)) for both normalized and non-normalized
OTU tables in both 2D and 3D formats for further analysis [55].
Phylogenetic analysis. Phylogenetic trees were produced as
necessary input for the phylogenetic beta diversity metrics (i.e.
UniFrac) in order to determine whether derived microbiome
communities were significantly different as an estimate of the
degree of divergence between different representative sequences
[53–55]. Phylogenetic trees were produced in Newick format
employing interactive tree of life (iTOL) interface [56].
Machine learning (randomForest modeling with Boruta
feature selection and LEfSe). In order to supplement the data
obtained from the taxonomically binned reports, alpha diversity,
beta diversity, and phylogenetic data sets, a machine learning
pipeline was written to study the patterns that can be detected
within the sub-groups of various microbiomes [33,38,39,57–63].
Machine learning algorithms are useful in determining the
strength of meta data clusters (bagging, binning, etc.) as well as
listing the most important variables involved in discriminating two
groups of samples (feature selection). The algorithm randomForest
enabled classification of groups of samples by constructing
a classification tree, randomly sampling the predictors, choosing
the best splitting variables, and predicting new data by combining
the predictions from all trees in order to estimate the error rate
[‘‘out-of-bag’’ (OOB)] and list the highest performing variables.
We secondarily applied the R package Boruta to explicitly perform
feature selection [33,39,58–60]. Linear discriminate analysis effect
size (LEfSe) is a novel method developed to support for high
dimensional class comparisons in metagenomics analysis [61].
LEfSe combines the standard tests for statistical significance
(Kruskal-Wallis test and pairwise Wilcoxon test) with linear
discriminate analysis for feature selection. In addition to detecting
significant features, it also ranks features by effect size, which put
features explain most of the biological difference at top. Pregnant
and Non-pregnant were indicated as two classes with no subclass
indicated. Alpha value for the factorial Kruskal-Wallis test is 0.05.
Threshold on the logarithmic LDA score for discriminative
features is 2.0.
Supporting Information
Figure S1 Accuracy of phenotypic predictions from
microbiome composition by randomForest. OTU abun-
dances using increasingly many minimal row contributions were
used by RF machine learning to predict clinical metadata
including pregnancy status, vaginal sampling subsite, subject body
mass index, and race/ethnicity. Pregnancy was extremely well
predicted by OTU features (Scott’s pi .0.8, as compared to
a random baseline of 0), exceeding the (still high) accuracy of other
metadata predictions.
(TIF)
Figure S2 Supervised (machine) learning with defini-
tion by randomForest and confirmation by Boruta
feature selection enables visualization of bacterial taxa
contributing to clustering of vaginal communities in
pregnancy. Bacterial taxa (leftmost column) were defined by
randomForest (Table S1) and confirmed by Boruta feature
selection. Taxa are sorted first by Mann-Whitney U score,
followed by the largest disparity in medians for each group. Taxa
represent the lowest taxonomic depth (Genus) that are labeled by
RDP Classifier (at $80% bootstrap cut off). Boxes represent the
first quartile, median, and third quartile of the distribution of
OTUs for each sample group. Empty circles represent outliers that
are 1.5-fold greater than the respective interquartile ranges.
(TIF)
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crete vaginal subsites. Bacterial taxa were selected as
significantly differentially abundant between pregnant and non-
pregnant communities by virtue of discrete sampling site and
displayed by LDA Effect Size (LEfSe) algorithm. Taxa level
projections are defined by pregnancy at each subsite, with specific
Lactobacillus species detected consistently among pregnant individ-
uals.
(TIF)
Table S1 Estimated error rate of the randomForest simulation
by virtue of potentially contributable clinical metadata (pregnancy,
BMI, vaginal sampling site, and ethnicity) following abundant
OTU pipeline for denoising of dataset. Top row header: Minimal
row contribution cut off sum for each OTU to determine the best
performing data set (i.e., contains the most discriminative features
with least amount of noise). When describing estimated error rate
per minimal row contribution, pregnancy was retained as the only
significant clinical metadata category in the model simulation that
had an acceptable level of estimated error (,10%, in bold face
type).
(DOC)
Table S2 Estimated error rate of the randomForest simulation
by virtue of potentially contributable clinical meta data (pregnan-
cy, BMI, vaginal sampling site, and ethnicity) following QIIME
pipeline for denoising of dataset. Top row header: Minimal row
contribution cut off sum for each OTU to determine the best
performing data set (i.e., contains the most discriminative features
with least amount of noise). When describing estimated error rate
per minimal row contribution, pregnancy was retained as the only
significant clinical metadata category in the model simulation that
had an acceptable level of estimated error (,10%, in bold face
type).
(DOC)
Table S3 The OTUs selected by Boruta feature selection are
assigned to the species level by realigned to Greengenes database
and BLAST with NCBI microbial database. Top OTUs identified
by LEfSe are marked with an asterics.
(DOC)
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